Next Generation News and Research

RSS

Accelerating Antibody Discovery with Next-Generation Single-Cell Analysis

Accelerating antibody discovery using picodroplet technology for single cell analysis to condense discovery times down to 1-2 days.

From Fluidic Sciences and Sphere Bio 22 Apr 2020

Discovery could open door to the development of new anti-cancer drugs

A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.

20 Apr 2020

BGU researchers develop new type of self-sterilizing air filter

With the worldwide focus on coronavirus prevention and transmission, a new type of air-filter that self-sterilizes and decontaminates is being developed at Ben-Gurion University of the Negev in Beer-Sheva, Israel based on water filtration technology.

20 Apr 2020

Activating a braking mechanism against cancer

A team has identified the binding site where drug compounds could activate a braking mechanism against runaway growth of cancer.

20 Apr 2020

New COVID-19 test is eight times faster, can help locate asymptomatic carriers

A team of Israeli researchers is using AI to develop an algorithm-based test that can speed COVID-19 testing eightfold and help locate asymptomatic carriers, funded by a grant from the Ben-Gurion University Covid-19 Effort.

20 Apr 2020

RIT researchers develop miniature lab device to detect bacteria, viruses

Engineering researchers developed a next-generation miniature lab device that uses magnetic nano-beads to isolate minute bacterial particles that cause diseases.

18 Apr 2020

COVID-19: AGS reinforces the need for medical supplies, telehealth in older adult care

In a new series of letters sent yesterday to Congressional leaders, Vice President Pence, and White House Coronavirus Task Force Coordinator Deborah Birx, MD, experts at the American Geriatrics Society continued to reinforce the need for medical supplies, telehealth, expertise in older adult care, and a range of other priorities as the federal government plans the next phase of America's response to COVID-19.

18 Apr 2020

Scripps Research establishes collaborative global effort to rapidly find drugs against COVID-19

With the COVID-19 pandemic continuing to spread across the globe, Scripps Research has quickly established an international network of collaborating scientific laboratories to leverage ReFRAME, the world's leading drug repurposing collection, to find antiviral compounds against the novel coronavirus.

16 Apr 2020

Canadian Coalition Fosters Collaboration in Fight Against COVID-19

A group of Canadian biotech companies are joining forces in the war on COVID-19 with an open-source model using next-generation antidotes known as nanobodies1.

From SignalChem Biotech Inc. 16 Apr 2020

Study reveals molecular causes of brain asymmetry

Scientists may have solved one of the most puzzling and persistent mysteries in neuroscience: why some people are "right-brained" while others are "left-brained."

15 Apr 2020

Harnessing power of cancer gene could lead to first curative treatment for heart disease

Researchers trying to turn off a gene that allows cancers to spread have made a surprising U-turn. By making the gene overactive and functional in the hearts of mice, they have triggered heart cell regeneration.

15 Apr 2020

Potential cure for heart disease via cancer gene upregulation

Researchers have found that by switching on a gene that promotes the spread of cancers, they can enhance the regeneration of damaged heart muscle. The study results, published in April 2020 in the journal Nature Communication, could mark the beginning of curative therapy for heart disease.

14 Apr 2020

Where cancers spread can give specific insights on disease traits

Kidney cancers that metastasize to the pancreas have a fundamentally different biology from those that metastasize elsewhere, with characteristics that can influence successful treatment, a study led by investigators with the UT Southwestern Kidney Cancer Program suggests.

12 Apr 2020

IBM employees produce protective face visors for hospitals

IBM staff with 3D printers are volunteering to turn their devices and skills to help alleviate the shortage of protective face visors for hospitals. Within just the first few days of a rallying call for help, a shipment of 20 visors was created and sent to a grateful University Hospital Southampton.

From IBM Watson 10 Apr 2020

3D printing silicone for breathing apparatus to help handle the COVID-19 pandemic

The COVID-19 pandemic is exhausting the healthcare resources of many countries, both developed and developing. With the escalating volume of patients who need intensive care and ventilation, breathing masks have become a high-priority item that many medical companies are racing to fill orders for in many parts of the world.

9 Apr 2020

Next-Generation Microscopy Image Analysis with Deep-Learning Technology

Image analysis is a critical part of many life science applications. Analyses that rely on segmentation to extract targets, such as cells and organelles, from the rest of the image are commonplace.

From Evident Corporation - Life Sciences 8 Apr 2020

Experimental drug APN01 prevents COVID-19 infection in the lab

With the world gripped with the COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is a frantic rush to find an effective drug that can be used to treat the disease.

6 Apr 2020

First genome sequences of SARS-CoV-2 viruses in Austria openly available

The first 21 SARS-CoV-2 genomes in Austria have now been completed and published within the scope of the “Mutational Dynamics of SARS-CoV-2” project recently launched by CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences, in close collaboration with the Medical University of Vienna.

3 Apr 2020

Excess cardiac myosin worsens damage to heart tissue during a heart attack

A prevalent heart protein known as cardiac myosin, which is released into the body when a person suffers a heart attack, can cause blood to thicken or clot--worsening damage to heart tissue, a new study shows.

2 Apr 2020